PL3399962T3 - Kompozycja okulistyczna do leczenia choroby suchego oka - Google Patents
Kompozycja okulistyczna do leczenia choroby suchego okaInfo
- Publication number
- PL3399962T3 PL3399962T3 PL17832066T PL17832066T PL3399962T3 PL 3399962 T3 PL3399962 T3 PL 3399962T3 PL 17832066 T PL17832066 T PL 17832066T PL 17832066 T PL17832066 T PL 17832066T PL 3399962 T3 PL3399962 T3 PL 3399962T3
- Authority
- PL
- Poland
- Prior art keywords
- treatment
- dry eye
- ophthalmic composition
- eye disease
- ophthalmic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1468—Containers characterised by specific material properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/06—Ampoules or carpules
- A61J1/067—Flexible ampoules, the contents of which are expelled by squeezing
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16206735 | 2016-12-23 | ||
| EP17165578 | 2017-04-07 | ||
| EP17832066.9A EP3399962B1 (en) | 2016-12-23 | 2017-12-20 | Ophthalmic composition for treatment of dry eye disease |
| PCT/EP2017/083770 WO2018115097A1 (en) | 2016-12-23 | 2017-12-20 | Ophthalmic composition for treatment of dry eye disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3399962T3 true PL3399962T3 (pl) | 2021-02-08 |
Family
ID=61002978
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL17832066T PL3399962T3 (pl) | 2016-12-23 | 2017-12-20 | Kompozycja okulistyczna do leczenia choroby suchego oka |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US20180360908A1 (pl) |
| EP (3) | EP3399962B1 (pl) |
| JP (2) | JP7032404B2 (pl) |
| KR (1) | KR102288022B1 (pl) |
| CN (1) | CN110267645A (pl) |
| AU (1) | AU2017384650B2 (pl) |
| BR (1) | BR112019012791A2 (pl) |
| CA (1) | CA3045743C (pl) |
| DK (1) | DK3399962T3 (pl) |
| ES (2) | ES2965883T3 (pl) |
| MX (1) | MX2019007587A (pl) |
| PL (1) | PL3399962T3 (pl) |
| PT (1) | PT3399962T (pl) |
| WO (1) | WO2018115097A1 (pl) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2564502T3 (es) | 2010-03-17 | 2016-03-23 | Novaliq Gmbh | Composición farmacéutica para el tratamiento de la presión intraocular aumentada |
| EP2444063A1 (en) | 2010-10-20 | 2012-04-25 | Novaliq GmbH | Liquid pharmaceutical compositions for the delivery of active ingredients |
| PL3181119T3 (pl) | 2012-09-12 | 2020-01-31 | Novaliq Gmbh | Kompozycje semifluorowanych alkanów do zastosowania w leczeniu suchego zapalenia spojówki i rogówki |
| CN113679698B (zh) | 2012-09-12 | 2022-07-26 | 诺瓦利克有限责任公司 | 包含半氟化烷烃的混合物的组合物 |
| AU2014295052B2 (en) | 2013-07-23 | 2018-08-30 | Novaliq Gmbh | Stabilized antibody compositions |
| CN111743882A (zh) | 2015-09-30 | 2020-10-09 | 诺瓦利克有限责任公司 | 半氟化化合物和其组合物 |
| ES2803248T3 (es) | 2015-09-30 | 2021-01-25 | Novaliq Gmbh | 2-perfluorohexil octano para administración oftálmica |
| ES2763121T3 (es) | 2016-06-23 | 2020-05-27 | Novaliq Gmbh | Método de administración tópica |
| ES2969758T3 (es) | 2016-09-22 | 2024-05-22 | Novaliq Gmbh | Composiciones farmacéuticas para usar en la terapia de la blefaritis |
| CA3036306C (en) | 2016-09-23 | 2024-05-14 | Novaliq Gmbh | Ophthalmic compositions comprising ciclosporin |
| CN110678207B (zh) | 2017-04-21 | 2024-08-02 | 德马利克治疗公司 | 碘组合物 |
| US11278503B2 (en) | 2017-05-12 | 2022-03-22 | Novaliq Gmbh | Pharmaceutical compositions comprising semifluorinated alkanes for the treatment of contact lense-related conditions |
| CN111372566A (zh) | 2017-09-27 | 2020-07-03 | 诺瓦利克有限责任公司 | 用于治疗眼部疾病的包含拉坦前列素的眼科用组合物 |
| WO2019068763A1 (en) | 2017-10-04 | 2019-04-11 | Novaliq Gmbh | OPHTHALMIC COMPOSITIONS COMPRISING F6H8 |
| WO2019166631A1 (en) | 2018-03-02 | 2019-09-06 | Novaliq Gmbh | Pharmaceutical compositions comprising nebivolol |
| WO2020074697A1 (en) * | 2018-10-12 | 2020-04-16 | Novaliq Gmbh | Ophthalmic composition for treatment of dry eye disease |
| WO2020239646A1 (en) * | 2019-05-24 | 2020-12-03 | Novaliq Gmbh | Ophthalmic composition for the treatment of ocular allergy |
| MX2022002667A (es) * | 2019-09-06 | 2022-04-07 | Novaliq Gmbh | Composicion oftalmica para el tratamiento de uveitis. |
| EP3861857A1 (en) * | 2020-02-07 | 2021-08-11 | Novaliq GmbH | Antiparasitic compositions |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2335735A1 (en) * | 2009-12-14 | 2011-06-22 | Novaliq GmbH | Pharmaceutical composition for treatment of dry eye syndrome |
| US9549966B2 (en) * | 2012-02-21 | 2017-01-24 | Massachusetts Eye & Ear Infirmary | Inflammatory eye disorders |
| US9878000B2 (en) * | 2012-06-20 | 2018-01-30 | University Of Waterloo | Mucoadhesive nanoparticle composition comprising immunosuppresant and methods of use thereof |
| CN113679698B (zh) * | 2012-09-12 | 2022-07-26 | 诺瓦利克有限责任公司 | 包含半氟化烷烃的混合物的组合物 |
| CA2891686A1 (en) * | 2012-12-18 | 2014-06-26 | Novartis Ag | Compositions and methods that utilize a peptide tag that binds to hyaluronan |
| EP3179975A4 (en) * | 2014-08-13 | 2018-04-18 | University of Florida Research Foundation, Inc. | Preservative removal from eye drops |
-
2017
- 2017-12-20 CN CN201780079941.0A patent/CN110267645A/zh active Pending
- 2017-12-20 AU AU2017384650A patent/AU2017384650B2/en active Active
- 2017-12-20 KR KR1020197021384A patent/KR102288022B1/ko active IP Right Grant
- 2017-12-20 PT PT178320669T patent/PT3399962T/pt unknown
- 2017-12-20 EP EP17832066.9A patent/EP3399962B1/en active Active
- 2017-12-20 JP JP2019533180A patent/JP7032404B2/ja active Active
- 2017-12-20 ES ES20178792T patent/ES2965883T3/es active Active
- 2017-12-20 MX MX2019007587A patent/MX2019007587A/es unknown
- 2017-12-20 DK DK17832066.9T patent/DK3399962T3/da active
- 2017-12-20 BR BR112019012791A patent/BR112019012791A2/pt active Search and Examination
- 2017-12-20 ES ES17832066T patent/ES2819005T3/es active Active
- 2017-12-20 CA CA3045743A patent/CA3045743C/en active Active
- 2017-12-20 EP EP20178792.6A patent/EP3777830B1/en active Active
- 2017-12-20 PL PL17832066T patent/PL3399962T3/pl unknown
- 2017-12-20 EP EP23212280.4A patent/EP4374851A3/en active Pending
- 2017-12-20 WO PCT/EP2017/083770 patent/WO2018115097A1/en active Application Filing
-
2018
- 2018-08-22 US US16/109,127 patent/US20180360908A1/en not_active Abandoned
-
2021
- 2021-12-31 JP JP2021215498A patent/JP2022050514A/ja not_active Withdrawn
-
2022
- 2022-09-19 US US17/933,471 patent/US20230043641A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| BR112019012791A2 (pt) | 2019-12-03 |
| CA3045743C (en) | 2023-08-29 |
| EP3399962B1 (en) | 2020-06-10 |
| EP4374851A3 (en) | 2024-08-21 |
| WO2018115097A9 (en) | 2018-08-23 |
| EP3777830B1 (en) | 2023-11-29 |
| ES2819005T3 (es) | 2021-04-14 |
| KR20190100283A (ko) | 2019-08-28 |
| JP7032404B2 (ja) | 2022-03-08 |
| JP2022050514A (ja) | 2022-03-30 |
| EP3777830C0 (en) | 2023-11-29 |
| KR102288022B1 (ko) | 2021-08-10 |
| AU2017384650B2 (en) | 2021-02-18 |
| WO2018115097A1 (en) | 2018-06-28 |
| JP2020502197A (ja) | 2020-01-23 |
| EP4374851A2 (en) | 2024-05-29 |
| DK3399962T3 (da) | 2020-09-07 |
| AU2017384650A1 (en) | 2019-07-04 |
| EP3777830A1 (en) | 2021-02-17 |
| ES2965883T3 (es) | 2024-04-17 |
| MX2019007587A (es) | 2019-12-16 |
| US20230043641A1 (en) | 2023-02-09 |
| EP3399962A1 (en) | 2018-11-14 |
| CN110267645A (zh) | 2019-09-20 |
| PT3399962T (pt) | 2020-09-03 |
| US20180360908A1 (en) | 2018-12-20 |
| CA3045743A1 (en) | 2018-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT3399962T (pt) | Composição oftálmica para o tratamento da doença do olho seco | |
| HK1258588A1 (zh) | 用於治療眼科疾病的化合物和製劑 | |
| IL281773A (en) | Eye preparation for the treatment of dry eye disease | |
| HK1231417A1 (zh) | 用於治療眼科疾病和障礙的化合物 | |
| EP3390634A4 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF EYE DISEASES | |
| IL246791A0 (en) | Compositions and methods for treating eye diseases | |
| EP3261620A4 (en) | Methods and compositions for treating dry eye disease and other eye disorders | |
| PL3419622T3 (pl) | Leczenie neurodegeneracyjnej choroby oczu przy użyciu pridopidyny | |
| EP3351219A4 (en) | MATERIAL FOR THE OPTICAL TREATMENT OF OCULAR DISEASES | |
| GB2541840B (en) | Ophthalmic composition for the treatment of ocular infection | |
| SI3210973T1 (sl) | Heteroarilne spojine za zdravljenje oftalmičnih bolezni | |
| IL269698B (en) | Methods for preventing or treating eye diseases | |
| IL259381B (en) | Miravegron for the treatment of retinal diseases | |
| PL3689341T3 (pl) | Gabapentyna okulistyczna do leczenia deepitelializacji rogówki | |
| PL3229780T3 (pl) | Kompozycje okulistyczne do zastosowania w leczeniu zespołu suchego oka | |
| GB201910645D0 (en) | Treatment for dry eye disease | |
| SG11202005278PA (en) | Compounds for treating eye diseases and methods thereof | |
| PL3302463T3 (pl) | Zastosowanie 3 deoksyantocyjanidyn w leczeniu chorób oczu | |
| IL263837A (en) | Treatment of ocular disease | |
| ZA201906465B (en) | Compositions and methods for treating dry eye diseases | |
| GB201610938D0 (en) | Treatment of ocular disease | |
| GB201705435D0 (en) | Treatment of ocular disease | |
| AU2016905281A0 (en) | Pharmaceutical composition for treatment of an eye disease or condition | |
| AU2016904360A0 (en) | Pharmaceutical composition for treatment of an eye disease or condition | |
| GB201621398D0 (en) | Treatment of emt-associated disease |